Dengue fever in a multiple sclerosis patient taking ocrelizumab: Clinical commentary

Dengue fever in a multiple sclerosis patient taking ocrelizumab: Clinical commentary

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Multiple sclerosis 2021-11, Vol.27 (13), p.2118-2119
Hauptverfasser: Alonso, Ricardo, Galleguillos, Lorna
Format: Artikel
Sprache:eng
Schlagworte:
Antibodies, Monoclonal, Humanized - adverse effects
Dengue - drug therapy
Dengue fever
Fever
Humans
Monoclonal antibodies
Multiple sclerosis
Multiple Sclerosis - drug therapy
Multiple Sclerosis, Chronic Progressive
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2119
container_issue 13
container_start_page 2118
container_title Multiple sclerosis
container_volume 27
creator Alonso, Ricardo
Galleguillos, Lorna
description
doi_str_mv 10.1177/13524585211039750
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2566031432</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_13524585211039750</sage_id><sourcerecordid>2566031432</sourcerecordid><originalsourceid>FETCH-LOGICAL-c368t-e0ecb8fc5320d89c606be59ddbd22b53fcfd04da97f5cca2698e2af0cb97e52c3</originalsourceid><addsrcrecordid>eNp1kMtOwzAQRS0EoqXwAWyQJTZsUvyI45gdKk-pEpuyjhxnXLk4SYkTJPh6XLWABGI1I82ZO3MvQqeUTCmV8pJywVKRC0Yp4UoKsofGNJUyIUqS_djHebIBRugohBUhREouDtGIp2mqmFRjtLiBZjkAtvAGHXYN1rgefO_WHnAwHro2uIDXunfQ9LjXL65Z4tZ04N3HUOvyCs-8a5zRHpu2riOku_djdGC1D3CyqxP0fHe7mD0k86f7x9n1PDE8y_sECJgyt0ZwRqpcmYxkJQhVVWXFWCm4NbYiaaWVtMIYzTKVA9OWmFJJEMzwCbrY6q679nWA0Be1Cwa81w20QyiYyDLCacpZRM9_oat26Jr4XaRUzE9yySNFt5SJvkMHtlh3ro6OCkqKTeTFn8jjztlOeShrqL43vjKOwHQLBL2En7P_K34CaMCJpQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2591107373</pqid></control><display><type>article</type><title>Dengue fever in a multiple sclerosis patient taking ocrelizumab: Clinical commentary</title><source>MEDLINE</source><source>SAGE Complete A-Z List</source><creator>Alonso, Ricardo ; Galleguillos, Lorna</creator><creatorcontrib>Alonso, Ricardo ; Galleguillos, Lorna</creatorcontrib><identifier>ISSN: 1352-4585</identifier><identifier>EISSN: 1477-0970</identifier><identifier>DOI: 10.1177/13524585211039750</identifier><identifier>PMID: 34449279</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>Antibodies, Monoclonal, Humanized - adverse effects ; Dengue - drug therapy ; Dengue fever ; Fever ; Humans ; Monoclonal antibodies ; Multiple sclerosis ; Multiple Sclerosis - drug therapy ; Multiple Sclerosis, Chronic Progressive</subject><ispartof>Multiple sclerosis, 2021-11, Vol.27 (13), p.2118-2119</ispartof><rights>The Author(s), 2021</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c368t-e0ecb8fc5320d89c606be59ddbd22b53fcfd04da97f5cca2698e2af0cb97e52c3</citedby><cites>FETCH-LOGICAL-c368t-e0ecb8fc5320d89c606be59ddbd22b53fcfd04da97f5cca2698e2af0cb97e52c3</cites><orcidid>0000-0001-9955-8343</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/13524585211039750$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/13524585211039750$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,780,784,21810,27915,27916,43612,43613</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34449279$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Alonso, Ricardo</creatorcontrib><creatorcontrib>Galleguillos, Lorna</creatorcontrib><title>Dengue fever in a multiple sclerosis patient taking ocrelizumab: Clinical commentary</title><title>Multiple sclerosis</title><addtitle>Mult Scler</addtitle><subject>Antibodies, Monoclonal, Humanized - adverse effects</subject><subject>Dengue - drug therapy</subject><subject>Dengue fever</subject><subject>Fever</subject><subject>Humans</subject><subject>Monoclonal antibodies</subject><subject>Multiple sclerosis</subject><subject>Multiple Sclerosis - drug therapy</subject><subject>Multiple Sclerosis, Chronic Progressive</subject><issn>1352-4585</issn><issn>1477-0970</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kMtOwzAQRS0EoqXwAWyQJTZsUvyI45gdKk-pEpuyjhxnXLk4SYkTJPh6XLWABGI1I82ZO3MvQqeUTCmV8pJywVKRC0Yp4UoKsofGNJUyIUqS_djHebIBRugohBUhREouDtGIp2mqmFRjtLiBZjkAtvAGHXYN1rgefO_WHnAwHro2uIDXunfQ9LjXL65Z4tZ04N3HUOvyCs-8a5zRHpu2riOku_djdGC1D3CyqxP0fHe7mD0k86f7x9n1PDE8y_sECJgyt0ZwRqpcmYxkJQhVVWXFWCm4NbYiaaWVtMIYzTKVA9OWmFJJEMzwCbrY6q679nWA0Be1Cwa81w20QyiYyDLCacpZRM9_oat26Jr4XaRUzE9yySNFt5SJvkMHtlh3ro6OCkqKTeTFn8jjztlOeShrqL43vjKOwHQLBL2En7P_K34CaMCJpQ</recordid><startdate>202111</startdate><enddate>202111</enddate><creator>Alonso, Ricardo</creator><creator>Galleguillos, Lorna</creator><general>SAGE Publications</general><general>Sage Publications Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-9955-8343</orcidid></search><sort><creationdate>202111</creationdate><title>Dengue fever in a multiple sclerosis patient taking ocrelizumab: Clinical commentary</title><author>Alonso, Ricardo ; Galleguillos, Lorna</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c368t-e0ecb8fc5320d89c606be59ddbd22b53fcfd04da97f5cca2698e2af0cb97e52c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Antibodies, Monoclonal, Humanized - adverse effects</topic><topic>Dengue - drug therapy</topic><topic>Dengue fever</topic><topic>Fever</topic><topic>Humans</topic><topic>Monoclonal antibodies</topic><topic>Multiple sclerosis</topic><topic>Multiple Sclerosis - drug therapy</topic><topic>Multiple Sclerosis, Chronic Progressive</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Alonso, Ricardo</creatorcontrib><creatorcontrib>Galleguillos, Lorna</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Multiple sclerosis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Alonso, Ricardo</au><au>Galleguillos, Lorna</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dengue fever in a multiple sclerosis patient taking ocrelizumab: Clinical commentary</atitle><jtitle>Multiple sclerosis</jtitle><addtitle>Mult Scler</addtitle><date>2021-11</date><risdate>2021</risdate><volume>27</volume><issue>13</issue><spage>2118</spage><epage>2119</epage><pages>2118-2119</pages><issn>1352-4585</issn><eissn>1477-0970</eissn><cop>London, England</cop><pub>SAGE Publications</pub><pmid>34449279</pmid><doi>10.1177/13524585211039750</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0001-9955-8343</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1352-4585
ispartof Multiple sclerosis, 2021-11, Vol.27 (13), p.2118-2119
issn 1352-4585
1477-0970
language eng
recordid cdi_proquest_miscellaneous_2566031432
source MEDLINE; SAGE Complete A-Z List
subjects Antibodies, Monoclonal, Humanized - adverse effects
Dengue - drug therapy
Dengue fever
Fever
Humans
Monoclonal antibodies
Multiple sclerosis
Multiple Sclerosis - drug therapy
Multiple Sclerosis, Chronic Progressive
title Dengue fever in a multiple sclerosis patient taking ocrelizumab: Clinical commentary
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T05%3A22%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dengue%20fever%20in%20a%20multiple%20sclerosis%20patient%20taking%20ocrelizumab:%20Clinical%20commentary&rft.jtitle=Multiple%20sclerosis&rft.au=Alonso,%20Ricardo&rft.date=2021-11&rft.volume=27&rft.issue=13&rft.spage=2118&rft.epage=2119&rft.pages=2118-2119&rft.issn=1352-4585&rft.eissn=1477-0970&rft_id=info:doi/10.1177/13524585211039750&rft_dat=%3Cproquest_cross%3E2566031432%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2591107373&rft_id=info:pmid/34449279&rft_sage_id=10.1177_13524585211039750&rfr_iscdi=true